Literature DB >> 16909431

TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.

Marion von Geldern1, Barbara Simm, Monika Braun, Elisabeth H Weiss, Dolores J Schendel, Christine S Falk.   

Abstract

Recent evidence suggests that the functional status of T cells activated independently from their TCR differs substantially from classical MHC-restricted T cells. Here, we show that TCR-independent, short-term stimulation via the common gamma-chain of the IL-2/IL-15 receptor induces non-MHC-restricted cytotoxicity and sustained cytokine secretion in purified CD4+ or CD8+ T cells. NK-like cytotoxicity is directed against MHC class I-negative targets and can be inhibited by classical and non-classical HLA class I molecules. Known inhibitory receptors, such as CD85j (ILT2) and leukocyte-associated Ig-like receptor-1, are not responsible for this HLA-mediated inhibition. NK-like cytotoxicity can be costimulated by NKG2D (CD314) triggering, but 2B4 (CD244) and DNAM-1 (CD226) are not involved. NK-like T cells display an activated phenotype and secrete various cytokines, including IFN-gamma, TNF-alpha, IL-5, IL-13 and MIP-1beta. Under normal conditions, HLA class I-mediated inhibition may function as a safety mechanism to prevent unbalanced cytokine production and effector killing mechanisms by T cells that were activated independently from their TCR. Non-MHC-restricted activity represents a functional status rather than a property of distinct T cell subpopulations. Thus, cytokine-induced, non-MHC-restricted T cells may be relevant in immune responses against tumors showing aberrant MHC expression through their capacities of cytokine production and direct tumor cell eradication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16909431     DOI: 10.1002/eji.200535387

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  T Cells Going Innate.

Authors:  Midas Seyda; Abdallah Elkhal; Markus Quante; Christine S Falk; Stefan G Tullius
Journal:  Trends Immunol       Date:  2016-07-08       Impact factor: 16.687

2.  Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.

Authors:  Christine M Freeman; MeiLan K Han; Fernando J Martinez; Susan Murray; Lyrica X Liu; Stephen W Chensue; Timothy J Polak; Joanne Sonstein; Jill C Todt; Theresa M Ames; Douglas A Arenberg; Catherine A Meldrum; Christi Getty; Lisa McCloskey; Jeffrey L Curtis
Journal:  J Immunol       Date:  2010-04-28       Impact factor: 5.422

3.  Enhanced lymphocyte interferon (IFN)-γ responses in a PTEN mutation-negative Cowden disease kindred.

Authors:  R Stevenson; A Fatehullah; I Jagan; R K Deevi; V Bingham; A E Irvine; M Armstrong; P J Morrison; I Dimmick; R Stewart; F C Campbell
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

Review 4.  Expansions of NK-like αβT cells with chronologic aging: novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells.

Authors:  Abbe N Vallejo; Robert G Mueller; David L Hamel; Amanda Way; Jeffrey A Dvergsten; Patricia Griffin; Anne B Newman
Journal:  Ageing Res Rev       Date:  2010-10-12       Impact factor: 10.895

5.  IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killing.

Authors:  Matthias Braun; Marie L Ress; Young-Eun Yoo; Claus J Scholz; Matthias Eyrich; Paul G Schlegel; Matthias Wölfl
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

6.  Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans.

Authors:  Elena Sandalova; Diletta Laccabue; Carolina Boni; Anthony T Tan; Katja Fink; Eng Eong Ooi; Robert Chua; Bahar Shafaeddin Schreve; Carlo Ferrari; Antonio Bertoletti
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

Review 7.  Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.

Authors:  Christiane Geiger; Elfriede Nössner; Bernhard Frankenberger; Christine S Falk; Heike Pohla; Dolores J Schendel
Journal:  J Mol Med (Berl)       Date:  2009-03-07       Impact factor: 4.599

8.  Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming.

Authors:  Xiao-Lin Li; Dongqing Zhang; David Knight; Yoshinobu Odaka; Jonathan Glass; J Michael Mathis; Qian-Jin Zhang
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

9.  CNS recruitment of CD8+ T lymphocytes specific for a peripheral virus infection triggers neuropathogenesis during polymicrobial challenge.

Authors:  Christine M Matullo; Kevin J O'Regan; Mark Curtis; Glenn F Rall
Journal:  PLoS Pathog       Date:  2011-12-22       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.